SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of February 2008
QIMONDA AG
Gustav-Heinemann-Ring 212
D-81739 Munich
Federal Republic of Germany
Tel: +49-89-60088-0
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this
Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange Act of 1934.
Yes No X
If Yes is marked, indicate below the file number assigned to the registrant in connection
with Rule 12g3-2(b):
82- .
This Report on Form 6-K is incorporated by reference into the registration statement on Form
F-3, File No. 333-145983, and into the prospectus that forms a part of this registration statement.
TABLE OF CONTENTS
Explanatory Note
This 6-K contains the following exhibits, which are hereby incorporated by reference as
Exhibits 3(i), 10(iv) and 10(v) respectively, to our Registration Statement on Form F-3,
Registration No. 333-145983.
|
|
|
Exhibit |
|
|
No. |
|
Description |
3(i)
|
|
Articles of Association of Qimonda AG, as amended. (English translation) |
|
|
|
10(iv)
|
|
Amendment No. 5 to the Joint Venture Agreement between
Nanya Technology Corporation and Qimonda AG of November 13, 2007. |
|
|
|
10(v)
|
|
IT Transformation Agreement by and between Infineon Technologies AG and
Qimonda AG effective as of October 1, 2007. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
QIMONDA AG
|
|
Date: February 5, 2008 |
By: |
/s/ Kin Wah Loh
|
|
|
|
Kin Wah Loh |
|
|
|
Chief Executive Officer and
Chairman of the Management Board |
|
|
|
|
|
|
By: |
/s/ Dr. Michael Majerus
|
|
|
|
Dr. Michael Majerus |
|
|
|
Chief Financial Officer and
Member of the Management Board |
|
|